Launch of the European project RISK-HUNT3R The new Horizon 2020 project RISK-HUNT3R: RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs was launched on 1 June.
Effects of COVID-19 vaccination becoming increasingly visible In the past calendar week, there were 43% fewer hospital admissions of patients with COVID-19 compared to the week before.
People born in 1981 invited for COVID-19 vaccination As of today, people born in 1981 can schedule an appointment online via www.coronavaccinatie-afspraak.nl for vaccination by the Municipal Public Health Services (GGDs).
WHO Chemical Risk Assessment Workshop on new and emerging risks to human health from chemicals RIVM is hosting an international workshop on new and emerging risks from chemicals on 20 and 21 February 2019.
Possible health risks due to exposure to chromium-6 at tROM project Tilburg Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.
Kick off European Project VITAL: Vaccines and InfecTious diseases in the Ageing popuLation Recently, the EU-sponsored Vaccines and InfecTious diseases in the Ageing popuLation (VITAL) project was launched.
Long-term disruption of day/night rhythms increases risk of breast cancer and leads to gain in bodyweight Long-term disruption of day/night rhythms leads to an increase in breast cancer risk and bodyweight in mice susceptible to breast cancer.
High number of tick bites expected this summer It is expected that over the coming month, around half a million people will be bitten by a tick. Last month, considerably more tick bites have been reported compared to previous years.
Gardner Middlebrook Award 2015 to Dick van Soolingen RIVM congratulates Professor Dick van Soolingen, who was presented the highly coveted Gardner Middlebrook Award.
Annual report RIVM 2014 online In our annual report, we look back at compelling RIVM projects and research in 2014.